NRX Pharmaceuticals Inc banner

NRX Pharmaceuticals Inc
NASDAQ:NRXP

Watchlist Manager
NRX Pharmaceuticals Inc Logo
NRX Pharmaceuticals Inc
NASDAQ:NRXP
Watchlist
Price: 1.84 USD -3.16% Market Closed
Market Cap: $58.6m

Cash Flow Statement

Cash Flow Statement
NRX Pharmaceuticals Inc

Rotate your device to view
Cash Flow Statement
Currency: USD
Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025 Jun-2025 Sep-2025
Operating Cash Flow
Net Income
(0)
(0)
0
0
0
0
0
0
0
(0)
(1)
(27)
(27)
(64)
(93)
(81)
(88)
(60)
(40)
(37)
(39)
(36)
(30)
(26)
(25)
(20)
(25)
(24)
(34)
(38)
Depreciation & Amortization
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Stock-Based Compensation
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8
9
10
11
4
3
2
1
0
(0)
0
0
0
0
0
0
Other Non-Cash Items
0
0
0
(0)
0
0
0
(0)
(0)
(0)
0
22
14
41
60
38
44
18
(1)
3
6
6
3
1
2
1
9
11
22
26
Cash Taxes Paid
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Cash Interest Paid
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Change in Working Capital
(0)
(0)
(1)
(1)
(1)
(1)
(1)
(1)
(0)
(0)
0
1
(2)
(4)
(5)
(2)
(5)
(1)
1
(1)
5
3
5
5
9
8
5
3
(1)
(0)
Cash from Operating Activities
(0)
N/A
(1)
-14%
(0)
+12%
(1)
-21%
(1)
-8%
(1)
+2%
(1)
-32%
(1)
+28%
(1)
-9%
(1)
-2%
(1)
+6%
(4)
-491%
(15)
-316%
(27)
-81%
(38)
-41%
(45)
-20%
(48)
-8%
(43)
+12%
(40)
+7%
(35)
+11%
(28)
+20%
(27)
+6%
(22)
+19%
(19)
+11%
(14)
+27%
(12)
+16%
(11)
+9%
(10)
+2%
(12)
-14%
(12)
-5%
Investing Cash Flow
Capital Expenditures
0
0
0
0
0
0
0
0
0
0
0
0
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
0
(0)
0
0
0
0
0
Other Items
(69)
(69)
(1)
(1)
21
30
40
67
44
36
26
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(3)
Cash from Investing Activities
(69)
N/A
(69)
+0%
(1)
+99%
(1)
-82%
21
N/A
30
+43%
40
+35%
67
+66%
44
-33%
36
-19%
26
-27%
0
-99%
0
+8%
(0)
N/A
(0)
+82%
(0)
-43%
(0)
-2%
(0)
-12%
(0)
+12%
(0)
-10%
(0)
+45%
(0)
+50%
(0)
N/A
0
N/A
(0)
N/A
0
N/A
0
N/A
0
N/A
0
N/A
(3)
N/A
Financing Cash Flow
Net Issuance of Common Stock
0
70
0
0
(22)
(31)
(41)
(67)
(45)
(36)
(26)
14
16
54
54
62
60
23
23
2
8
9
9
9
7
6
6
7
4
14
Net Issuance of Debt
0
0
1
1
2
2
1
1
1
1
1
0
(1)
(1)
(1)
0
(1)
(1)
10
0
10
8
(3)
(5)
(5)
(3)
(2)
5
5
5
Other
(1)
(1)
(0)
0
0
0
0
0
0
0
0
0
11
11
11
0
0
0
0
0
1
0
0
0
(1)
1
3
3
3
1
Cash from Financing Activities
70
N/A
69
0%
1
-99%
1
+118%
(21)
N/A
(29)
-42%
(39)
-35%
(66)
-67%
(44)
+34%
(35)
+19%
(26)
+28%
15
N/A
26
+78%
64
+145%
63
0%
72
+13%
60
-17%
22
-63%
32
+46%
12
-63%
19
+61%
17
-8%
6
-64%
4
-35%
1
-77%
4
+385%
7
+67%
15
+96%
13
-12%
21
+59%
Change in Cash
Net Change in Cash
0
N/A
(0)
N/A
(0)
-8 017%
(0)
+39%
(0)
+48%
0
N/A
(0)
N/A
0
N/A
(0)
N/A
(0)
-11 762%
0
N/A
11
+2 832 800%
12
+2%
37
+221%
26
-30%
27
+5%
11
-59%
(21)
N/A
(8)
+63%
(24)
-214%
(10)
+60%
(9)
+2%
(15)
-65%
(15)
+2%
(13)
+14%
(7)
+44%
(3)
+57%
4
N/A
1
-76%
6
+446%
Free Cash Flow
Free Cash Flow
(0)
N/A
(1)
-14%
(0)
+12%
(1)
-21%
(1)
-8%
(1)
+2%
(1)
-32%
(1)
+28%
(1)
-9%
(1)
-2%
(1)
+6%
(4)
-491%
(15)
-316%
(27)
-81%
(38)
-41%
(45)
-20%
(48)
-8%
(43)
+12%
(40)
+7%
(35)
+11%
(28)
+20%
(27)
+6%
(22)
+19%
(19)
+11%
(14)
+27%
(12)
+16%
(11)
+9%
(10)
+2%
(12)
-14%
(12)
-5%
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett